Get started
Author

Zina B. Eminton

Observed names: Eminton, Zina, Z Eminton, Z. Eminton, Zina Eminton
Observed institutions: Maastricht University Medical Centre, Cancer Research UK, University Hospital Southampton NHS Foundation Trust, Duke Raleigh Hospital, Essen University Hospital, Universitätsklinikum Aachen, University of Southampton, RWTH Aachen University
ORCID: 0009-0001-2747-4279
Observed ORCID: 0009-0001-2747-4279
OpenAlex ID: A5042649331
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial
2020 · John A Bridgewater, Siân A Pugh, et al. · The Lancet Oncology · 252
PDF
Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial
2021 · Nick Curzen, Zoe Nicholas, et al. · European Heart Journal · 173
PDF
Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial
2024 · Robert S. Fichtinger, Luca A. Aldrighetti, et al. · Journal of Clinical Oncology · 88
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial
2023 · Miriam Santer, Megan Lawrence, et al. · BMJ · 61
PDF
Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure)
2023 · Andrew Flett, Anna Cebula, et al. · American Heart Journal · 37
PDF
Laparoscopic versus open resections in the posterosuperior liver segments within an enhanced recovery programme (ORANGE Segments): study protocol for a multicentre randomised controlled trial
2022 · Christoph Kuemmerli, Robert S. Fichtinger, et al. · Trials · 20
PDF
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women
2021 · Susanne Renz, Fay Chinnery, et al. · BMJ Open · 16
PDF
Laparoscopic versus open parenchymal preserving liver resections in the posterosuperior segments (ORANGE Segments): a multicentre, single-blind, randomised controlled trial
2025 · Jasper P. Sijberden, Christoph Kuemmerli, et al. · The Lancet Regional Health - Europe · 14
Randomized comparison of chest pain evaluation with FFRCT or standard care: Factors determining US costs
2022 · Mark A. Hlatky, Sam Wilding, et al. · Journal of cardiovascular computed tomography · 14
An Assessment of the Efficacy of Atorvastatin in Achieving Ldl Cholesterol Target Levels in Patients With Coronary Heart Disease: a General Practice Study
1999 · HAW Neil, G Fowler, et al. · International Journal of Clinical Practice · 11
PDF
An Assessment of the Efficacy of Atorvastatin in Treating Patients With Dyslipidaemia to Target Ldl‐cholesterol Goals: the Atorvastatin Matrix Study
1999 · D McVey, H Patel, et al. · International Journal of Clinical Practice · 10
384O Laparoscopic versus open hemihepatectomy: The ORANGE II PLUS multicenter randomized controlled trial
2021 · R.S. Fichtinger, L. Aldrighetti, et al. · Annals of Oncology · 9
PDF
Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT
2024 · Miriam Santer, Megan Lawrence, et al. · Health Technology Assessment · 8
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial
2023 · Sarah Pyne, Tracey H Sach, et al. · BMJ Open · 6
PDF
Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): Mature analysis of overall survival (OS) in the New EPOC randomised controlled trial
2017 · J. Bridgewater, S. Pugh, et al. · Annals of Oncology · 6
PDF
Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres
2023 · Dean Fennell, Daniel Griffiths, et al. · BMJ Open · 5
PDF
Factors that influence women’s enrolment and ongoing participation in a partially decentralised randomised controlled dermatology trial: a qualitative interview study with participants in the SAFA (Spironolactone for Adult Female Acne) trial
2023 · Cherish Boxall, Susanne Renz, et al. · Trials · 5
PDF
Social media recruitment enhances participant diversity in dermatology clinical trial: findings from the SAFA trial
2025 · Cherish Boxall, Susanne Renz, et al. · Trials · 4
PDF
Health-related quality of life in patients undergoing laparoscopic versus open hemihepatectomy: a secondary analysis of the ORANGE II PLUS randomised controlled, phase 3, superiority trial
2025 · Bram Olij, Bram Olij, et al. · The Lancet Regional Health - Europe · 4
PDF
A multicentre randomised controlled trial of a guided self-help cognitive behavioural therapy to MANage the impact of hot flushes and night sweats in patients with prostate CANcer undergoing androgen deprivation therapy (MANCAN2)
2023 · Simon Crabb, Alannah Morgan, et al. · Trials · 4
PDF
Self-help cognitive behavioural therapy for hot flushes and night sweats during androgen deprivation therapy for prostate cancer: the MANCAN2 randomized controlled trial
2026 · Simon J. Crabb, Alannah Morgan, et al. · British Journal of Cancer · 3
PDF
Healthcare Utilization, Costs, and Cost-Effectiveness of Patients Undergoing Laparoscopic and Open Hemihepatectomy: A Secondary Analysis of the ORANGE II PLUS Randomized Controlled, Phase 3, Superiority Trial
2025 · Bram Olij, Gabriela Pilz da Cunha, et al. · Annals of Surgical Oncology · 2
PDF
Abstract CT263: Efficacy and multiomic analysis of Niraparib in relapsed mesothelioma: NERO a randomized phase II trial
2025 · Dean Fennell, Kayleigh Hill, et al. · Cancer Research · 2
BRITISH, an ongoing randomised trial of implantable defibrillators for non-ischemic cardiomyopathy with severe LV impairment and myocardial scar: trial design and update.
2025 · Andrew Flett, Anna Cebula, et al. · Journal of Cardiovascular Magnetic Resonance · 2
MANCAN2: A multicentre randomised controlled trial of self-help cognitive behavioural therapy (CBT) to manage hot flush and night sweats (HFNS) symptoms in patients with prostate cancer receiving androgen deprivation therapy (ADT).
2024 · Simon J. Crabb, Alannah Morgan, et al. · Journal of Clinical Oncology · 2
Works count: 55
Citation count: 851
H-index: 11
I10-index: 12
Year
Topic
Type